폐기능 검사 시스템 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Pulmonary Function Testing Systems Market reached USD 2.9 billion in 2024 and is on track to expand at a CAGR of 6.6% between 2025 and 2034. This rapid growth is fueled by continuous advancements in diagnostic technologies, an aging population, increased awareness of early disease detection, and improved healthcare infrastructure. With respiratory diseases becoming more prevalent, healthcare providers are prioritizing early diagnosis and efficient disease management, which is significantly boosting the demand for advanced pulmonary function testing systems. Innovations in compact, high-precision devices are making pulmonary assessments more accessible across various healthcare settings. The shift toward cost-effective and user-friendly diagnostic tools is shaping the industry, driving greater adoption in clinical and home-based environments.

Market growth is further supported by ongoing investments in medical technology and digital integration, enhancing the efficiency and reliability of pulmonary assessments. The increasing need for continuous respiratory monitoring is pushing manufacturers to develop devices with improved functionality and accuracy. The rise of wearable and remote monitoring solutions is transforming respiratory diagnostics, making them more convenient for both patients and healthcare professionals. As the industry moves toward personalized medicine, pulmonary function testing systems are evolving to provide more precise and patient-specific insights. Preventive care initiatives and widespread screening programs are accelerating adoption, ensuring steady expansion in the coming years.

Portable and compact diagnostic devices are experiencing significant demand due to their ease of use and ability to provide precise results in various healthcare environments. The handheld segment led the market, generating USD 1.7 billion in revenue in 2024. These cost-efficient devices are favored over larger, laboratory-based equipment, particularly by smaller healthcare facilities that require affordable yet accurate respiratory assessments. Their flexibility in delivering real-time testing has led to increased adoption across multiple medical applications. As manufacturers refine device performance and enhance user convenience, the industry is shifting toward digital connectivity and remote monitoring capabilities. The rising demand for accurate and accessible pulmonary function testing solutions is driving innovation, reinforcing their essential role in modern healthcare systems.

Chronic respiratory conditions are a major factor driving market expansion, with chronic diseases accounting for a substantial portion of demand. The chronic obstructive pulmonary disease (COPD) segment held a 39.8% market share in 2024. The rising incidence of pulmonary disorders due to environmental pollutants and lifestyle factors has made pulmonary function testing a crucial part of routine healthcare. As chronic respiratory diseases become more prevalent, healthcare providers are investing in advanced diagnostic equipment to facilitate early intervention. The importance of early detection in slowing disease progression is increasing demand for precise pulmonary assessments. Advancements in testing technology are improving efficiency, thus offering better monitoring and disease management solutions. Expanding healthcare infrastructure is also improving access to state-of-the-art pulmonary function testing devices, driving overall market growth.

The US pulmonary function testing systems market was valued at USD 1.3 billion in 2024 and is projected to grow at a CAGR of 5.4% through 2034. As a global leader in medical technology, the US continues to integrate high-precision diagnostic tools into healthcare institutions, improving accuracy and efficiency in pulmonary assessments. The widespread adoption of digital and wireless-enabled devices is further streamlining pulmonary function testing, increasing overall market demand. With strong investments in healthcare innovation and a rising focus on early disease detection, the US market is well-positioned for consistent growth over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in prevalence of chronic respiratory diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Favourable government initiatives
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with pulmonary function testing devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Pricing analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Handheld
• 5.3 Tabletop

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Spirometry
• 6.3 Exercise stress test
• 6.4 Lung volume test
• 6.5 High altitude simulation testing
• 6.6 Gas diffusion test
• 6.7 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Chronic obstructive pulmonary disease
• 7.3 Asthma
• 7.4 Chronic shortness of breath
• 7.5 Pulmonary fibrosis
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals & clinics
• 8.3 Diagnostic centers
• 8.4 Homecare settings
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Baxter
• 10.2 CHEST M.I
• 10.3 COSMED
• 10.4 ECO MEDICS
• 10.5 FUKUDA SANGYO
• 10.6 GANSHORN SCHILLER GROUP
• 10.7 Geratherm Respiratory
• 10.8 medical equipment europe
• 10.9 MGC DIAGNOSTICS
• 10.10 MINATO MEDICAL SCIENCE
• 10.11 MORGAN
• 10.12 ndd Medical Technologies
• 10.13 PHILIPS
• 10.14 Vitalograph
• 10.15 Vyaire MEDICAL